What is the most common (MC) cause of gynecomastia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Cause of Gynecomastia

Physiologic gynecomastia is the most common cause of gynecomastia, occurring in up to 57% of men due to normal hormonal fluctuations. 1

Pathophysiology

  • Gynecomastia results from a hormonal imbalance between estrogens and androgens, leading to proliferation of glandular breast tissue 2
  • The condition presents as a soft, rubbery, or firm mobile mass directly under the nipple, often painful when present for less than 6 months 3
  • Gynecomastia is bilateral in approximately 50% of patients 3

Common Causes of Gynecomastia

Physiologic Causes (Most Common)

  • Neonatal period: Due to maternal estrogens 4
  • Puberty: Transient relative imbalances between androgens and estrogens during development 5
    • Pubertal gynecomastia is self-limited in 75-90% of adolescents and typically regresses over 1-3 years 5
  • Aging: Hormonal changes in older men 4

Pathologic Causes

  • Hormonal disorders:
    • Hyperprolactinemia 6
    • Hypogonadism (primary or secondary) 7
    • Thyroid dysfunction 6
  • Systemic diseases:
    • Liver cirrhosis 6
    • Renal insufficiency 4
  • Genetic conditions:
    • Klinefelter syndrome (significantly increases risk with a relative risk of 24.7) 6
  • Medications and substances:
    • Antiandrogens 3
    • Chemotherapeutic agents 6
    • Various other medications 3
  • Obesity:
    • Contributes to pseudogynecomastia but can also increase true gynecomastia through peripheral conversion of androgens to estrogens 6
  • Tumors (rare):
    • Adrenal tumors that secrete estrogen 6
    • Testicular tumors 7

Diagnostic Approach

  • Clinical evaluation should focus on:

    • Differentiating true gynecomastia from pseudogynecomastia (fatty tissue deposition rather than glandular tissue enlargement) 3
    • Evaluating medication history and temporal relationship between medication initiation and onset of gynecomastia 6
    • Assessing for underlying medical conditions 6
  • Physical examination should include:

    • Body habitus assessment and BMI calculation 3
    • Evaluation of virilization status by examining body hair patterns 3
    • Complete testicular examination 3
    • Assessment of prostate size and morphology 3
    • Visual field examination to detect signs of pituitary disorders 3

Management Considerations

  • Most cases of physiologic gynecomastia resolve spontaneously and require no treatment 1
  • For persistent, painful gynecomastia:
    • Patients with elevated baseline estradiol measurements should be referred to an endocrinologist 3
    • Estrogen receptor modulators may be considered for testosterone deficient patients 3
    • Surgical correction may be needed for cosmetic reasons or long-standing cases that have become fibrotic 3

Common Pitfalls

  • Failing to distinguish between true gynecomastia and pseudogynecomastia, especially in obese patients 6
  • Ordering unnecessary imaging in clear cases of gynecomastia, which can lead to additional unnecessary benign biopsies 3
  • Overlooking medication-induced causes, which are frequent contributors to breast enlargement 7
  • Delaying treatment in cases causing significant psychological distress, particularly among adolescents 1

References

Research

Gynecomastia: physiopathology, evaluation and treatment.

Sao Paulo medical journal = Revista paulista de medicina, 2012

Guideline

Gynecomastia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gynecomastia.

American family physician, 2012

Research

Management of Adolescent Gynecomastia: An Update.

Acta bio-medica : Atenei Parmensis, 2017

Guideline

Gynecomastia Risk Factors and Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gynecomastia.

Endocrinology and metabolism clinics of North America, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.